Free Trial

Craneware (LON:CRW) Stock Passes Above Two Hundred Day Moving Average of $2,257.27

Craneware logo with Medical background

Craneware plc (LON:CRW - Get Free Report) shares passed above its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of GBX 2,257.27 ($29.33) and traded as high as GBX 2,350 ($30.54). Craneware shares last traded at GBX 2,310 ($30.02), with a volume of 135,164 shares.

Analyst Ratings Changes

Separately, Berenberg Bank raised their price objective on Craneware from GBX 2,600 ($33.78) to GBX 2,700 ($35.08) and gave the stock a "buy" rating in a research report on Thursday, July 18th.

Get Our Latest Stock Report on CRW

Craneware Price Performance

The firm has a market capitalization of £812.36 million, a P/E ratio of 11,011.43 and a beta of 0.37. The stock has a 50 day moving average of GBX 2,340.62 and a two-hundred day moving average of GBX 2,257.27. The company has a debt-to-equity ratio of 19.15, a quick ratio of 1.00 and a current ratio of 0.78.

About Craneware

(Get Free Report)

Craneware plc, together with its subsidiaries, develops, licenses, and supports computer software for the healthcare industry in the United States. The company provides solutions, such as Trisus pricing transparency software; Trisus Pricing Analyzer, a solution that simplifies and automates the price modeling process; Trisus Chargemaster, an automated chargemaster management solution; InSight Medical Necessity, a solution that offers medical necessity for the United States payors; Trisus Claims Informatics, a retrospective charge capture analytical application that identifies areas of risk for its team to investigate; Trisus Supply, a solution that improves supplies reimbursement; and InSight Audit, an audit management solution for government and commercial payors.

Recommended Stories

→ Forget Trump and Kamala (From Investors Alley) (Ad)

Should you invest $1,000 in Craneware right now?

Before you consider Craneware, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Craneware wasn't on the list.

While Craneware currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The 10 Best AI Stocks to Own in 2024 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Is Palantir Heading for a $50 Price Target?
Rate Cuts Fuel Volatility: How Long Could it Last?
SMCI Stock: Is a Rebound Coming?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines